Novartis Bioventures Ltd Galera Therapeutics, Inc. (GRTX) insider trading activity

Novartis Bioventures LTD is of Galera Therapeutics, Inc.. Currently has a direct ownership of 2.47 Million shares of GRTX, which is worth approximately $197,436. The most recent transaction as insider was on Jun 19, 2020, when has been sold 1,001,312 shares (Common Stock) at a price of $8.25 per share, resulting in proceeds of $8,260,824. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.47M

0% 3M change

0% 12M change

Total Value Held $197,436

Novartis Bioventures Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 19 2020	SELL Open market or private sale	$8,260,824 $8.25 p/Share	1,001,312 Reduced 28.86%	2,467,961 Common Stock
Jun 18 2020	SELL Open market or private sale	$8,136 $9.04 p/Share	900 Reduced 0.03%	3,469,273 Common Stock
Jun 17 2020	SELL Open market or private sale	$42,846 $9.27 p/Share	4,622 Reduced 0.13%	3,470,173 Common Stock
Jun 16 2020	SELL Open market or private sale	$79,980 $9.3 p/Share	8,600 Reduced 0.25%	3,474,795 Common Stock
Jun 15 2020	SELL Open market or private sale	$55,784 $9.05 p/Share	6,164 Reduced 0.18%	3,483,395 Common Stock
Jun 12 2020	SELL Open market or private sale	$13,785 $9.19 p/Share	1,500 Reduced 0.04%	3,489,559 Common Stock
Jun 11 2020	SELL Open market or private sale	$66,312 $9.21 p/Share	7,200 Reduced 0.21%	3,491,059 Common Stock
Jun 10 2020	SELL Open market or private sale	$80,713 $9.46 p/Share	8,532 Reduced 0.24%	3,498,259 Common Stock
Jun 09 2020	SELL Open market or private sale	$65,660 $9.38 p/Share	7,000 Reduced 0.2%	3,506,791 Common Stock
Jun 08 2020	SELL Open market or private sale	$54,666 $9.66 p/Share	5,659 Reduced 0.16%	3,513,791 Common Stock
Jun 05 2020	SELL Open market or private sale	$83,578 $9.66 p/Share	8,652 Reduced 0.25%	3,519,450 Common Stock
Jun 04 2020	SELL Open market or private sale	$39,040 $9.55 p/Share	4,088 Reduced 0.12%	3,528,102 Common Stock
Jun 03 2020	SELL Open market or private sale	$50,934 $9.78 p/Share	5,208 Reduced 0.15%	3,532,190 Common Stock
Jun 02 2020	SELL Open market or private sale	$54,876 $9.68 p/Share	5,669 Reduced 0.16%	3,537,398 Common Stock

Also insider at

ATRX

Adhera Therapeutics, Inc. Healthcare

> 10% Shareholder

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

YMTX

YUMANITY THERAPEUTICS, INC. Healthcare

> 10% Shareholder

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

RARX

Ra Pharmaceuticals, Inc.

> 10% Shareholder

AADI

Aadi Bioscience, Inc. Healthcare

> 10% Shareholder

ALRN

AILERON THERAPEUTICS INC Healthcare

> 10% Shareholder

ALT

Altimmune, Inc. Healthcare

> 10% Shareholder

BCYC

BICYCLE THERAPEUTICS plc Healthcare

> 10% Shareholder

AKUS

Akouos, Inc. Healthcare

NBL